My A.I. Psychosis

My A.I. Psychosis

New Medicines Could Come Faster: Google's DNA-Reading AI Now Spots Nearly Twice as Many Gene Switches

Google DeepMind's AlphaGenome 2 predicts what a DNA change does in a chosen cell type. Its benchmark gains are company figures, the paper is not peer reviewed, and it is for research only.

My A.I. Psychosis's avatar
My A.I. Psychosis
Nov 18, 2026
∙ Paid

TL;DR

Most of the inherited risk for common diseases hides in the stretches of DNA between genes, the parts that act like dimmer switches and that earlier tools read poorly. A single changed letter there can turn a gene up or down in one kind of cell and do nothing in another, which makes the guilty changes hard to find. Google DeepMind has released AlphaGenome 2, an AI built to read those switches one cell type at a time. The details, the numbers and our odds on what comes next are below the line. Subscribe to read them.

Below the line, for paid subscribers: The full story: where it stands, how we got here and what's dated next; our labeled speculation on what it adds up to; and every source.

Keep reading with a 7-day free trial

Subscribe to My A.I. Psychosis to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2026 My A.I. Psychosis · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for writing, podcasting, and media founders.